logo
Plus   Neg
Share
Email

Green Mountain Coffee Q2 Profit Meets Estimates; Cuts FY12 Outlook

Green Mountain Coffee Roasters, Inc. (GMCR) reported second-quarter net income attributable to the company of $93.0 million or $0.58 per share, up from $65.4 million or $0.44 per share last year.

Excluding items, non-GAAP net income for the quarter was $101.7 million or $0.64 per share, compared to $71.5 million or $0.48 per share.

On average, 11 analysts polled by Thomson Reuters expected earnings of $0.64 per share for the quarter. Analysts' estimates typically exclude special items.

Net sales for the quarter increased 37 percent to $885.1 million from $647.7 million a year ago.

Analysts expected revenues of $971.65 million for the quarter.

Looking forward, Green Mountain Coffee Roasters expects third-quarter non-GAAP earnings of $0.48 to $0.53 per share on net sales ranging from $861 million to $897 million. Analysts expect the company to earn $0.72 per share on revenue of $1.05 billion for the third quarter.

For the fiscal 2012 , the company expects non-GAAP earnings of $2.40 to $2.50 per share and net sales of $3.8 billion to $4.0 billion, which represents a net growth of 45% to 50%. Previously, the company expected non-GAAP earnings of $2.55 to $2.65 per share and net sales growth of 60% to 65%.

Analysts expect the company to earn $2.67 per share on revenues of $4.27 billion for the fiscal 2012.

Additionally, Green Mountain Coffee Roasters said that it has reached a multiyear agreement with Eight O'Clock Coffee Company to make Eight O'Clock coffee, Tetley tea, and Good Earth tea available in K-Cup and Vue packs for Keurig Single Cup Brewing systems. Financial terms of the agreement were not disclosed.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT